Structure and glass transition temperature of amorphous dispersions of model pharmaceuticals with nucleobases from molecular dynamics
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60461373%3A22340%2F21%3A43923028" target="_blank" >RIV/60461373:22340/21:43923028 - isvavai.cz</a>
Result on the web
<a href="https://www.mdpi.com/1999-4923/13/8/1253" target="_blank" >https://www.mdpi.com/1999-4923/13/8/1253</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3390/pharmaceutics13081253" target="_blank" >10.3390/pharmaceutics13081253</a>
Alternative languages
Result language
angličtina
Original language name
Structure and glass transition temperature of amorphous dispersions of model pharmaceuticals with nucleobases from molecular dynamics
Original language description
Glass transition temperature (Tg) is an important material property, which predetermines the kinetic stability of amorphous solids. In the context of active pharmaceutical ingredients (API), there is motivation to maximize their Tg by forming amorphous mixtures with other chemicals, la-beled excipients. Molecular dynamics simulations are a natural computational tool to investigate the relationships between structure, dynamics, and cohesion of amorphous materials with an all-atom resolution. This work presents a computational study, addressing primarily the predictions of the glass transition temperatures of four selected API (carbamazepine, racemic ibuprofen, indo-methacin, and naproxen) with two nucleobases (adenine and cytosine). Since the classical non-po-larizable simulations fail to reach the quantitative accuracy of the predicted Tg, analyses of internal dynamics, hydrogen bonding, and cohesive forces in bulk phases of pure API and their mixtures with the nucleobases are performed to interpret the predicted trends. This manuscript reveals the method for a systematic search of beneficial pairs of API and excipients (with maximum Tg when mixed). Monitoring of transport and cohesive properties of API–excipients systems via molecular simulation will enable the design of such API formulations more efficiently in the future. © 2021 by the author. Licensee MDPI, Basel, Switzerland.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
10403 - Physical chemistry
Result continuities
Project
<a href="/en/project/GA19-02889S" target="_blank" >GA19-02889S: Stability of amorphous solid dispersions: Predictions by SAFT equations of state and their experimental verification</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2021
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
PHARMACEUTICS
ISSN
1999-4923
e-ISSN
—
Volume of the periodical
13
Issue of the periodical within the volume
8
Country of publishing house
CH - SWITZERLAND
Number of pages
14
Pages from-to
1253
UT code for WoS article
000690033300001
EID of the result in the Scopus database
2-s2.0-85113292646